CD4 and influenza: This fact underpins the feasibility of the development of new vaccination strategies for the elderly using vaccines based on CD4+ CTL NP epitopes, as it is well known that with age, the number of CD4+ CTLs increases, but the activity of these cells upon influenza vaccination remains unchanged [36].